Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2011 | 1 |
2015 | 2 |
2016 | 1 |
2018 | 1 |
2022 | 2 |
2023 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma.
N Engl J Med. 2015 Nov 5;373(19):1803-13. doi: 10.1056/NEJMoa1510665. Epub 2015 Sep 25.
N Engl J Med. 2015.
PMID: 26406148
Free PMC article.
Clinical Trial.
Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial.
Smith MR, Scher HI, Sandhu S, Efstathiou E, Lara PN Jr, Yu EY, George DJ, Chi KN, Saad F, Ståhl O, Olmos D, Danila DC, Mason GE, Espina BM, Zhao X, Urtishak KA, Francis P, Lopez-Gitlitz A, Fizazi K; GALAHAD investigators.
Smith MR, et al.
Lancet Oncol. 2022 Mar;23(3):362-373. doi: 10.1016/S1470-2045(21)00757-9. Epub 2022 Feb 4.
Lancet Oncol. 2022.
PMID: 35131040
Free PMC article.
Clinical Trial.
Item in Clipboard
Effect of docetaxel added to bicalutamide in Hormone-Naïve non-metastatic prostate cancer with rising PSA, a randomized clinical trial (SPCG-14).
Josefsson A, Jellvert Å, Holmberg E, Brasso K, Meidahl Petersen P, Aaltomaa S, Luukkaa M, Verhagen P, de Wit R, Ahlgren G, Andrén O, Castellanos E, Seke M, Widmark A, Damber JE; SPCG14-investigators.
Josefsson A, et al. Among authors: jellvert a.
Acta Oncol. 2023 Apr;62(4):372-380. doi: 10.1080/0284186X.2023.2199940. Epub 2023 Apr 19.
Acta Oncol. 2023.
PMID: 37073813
Clinical Trial.
Item in Clipboard
Ilixadencel, a Cell-based Immune Primer, plus Sunitinib Versus Sunitinib Alone in Metastatic Renal Cell Carcinoma: A Randomized Phase 2 Study.
Lindskog M, Laurell A, Kjellman A, Melichar B, Rey PM, Zieliński H, Villacampa F, Bigot P, Zoltan B, Parikh O, Alba DV, Jellvert Å, Flaskó T, Gallardo E, Caparrós MJR, Purkalne G, Suenaert P, Karlsson-Parra A, Ljungberg B.
Lindskog M, et al. Among authors: jellvert a.
Eur Urol Open Sci. 2022 Apr 26;40:38-45. doi: 10.1016/j.euros.2022.03.012. eCollection 2022 Jun.
Eur Urol Open Sci. 2022.
PMID: 35638086
Free PMC article.
Item in Clipboard
Castration is a prerequisite for the inhibitory effect of metronomic chemotherapy on the growth of experimental castration-resistant prostate cancer.
Jellvert Å, Åhs D, Olausson J, Franck Lissbrant I, Damber JE, Welén K.
Jellvert Å, et al.
Acta Oncol. 2018 Jul;57(7):895-901. doi: 10.1080/0284186X.2017.1423178. Epub 2018 Jan 4.
Acta Oncol. 2018.
PMID: 29299975
Item in Clipboard
Impact of quality indicators on adherence to National and European guidelines for renal cell carcinoma.
Thorstenson A, Harmenberg U, Lindblad P, Ljungberg B, Lundstam S; Swedish Kidney Cancer Quality Register Group.
Thorstenson A, et al.
Scand J Urol. 2016;50(1):2-8. doi: 10.3109/21681805.2015.1059882. Epub 2015 Jul 23.
Scand J Urol. 2016.
PMID: 26202573
Item in Clipboard
Effective oral combination metronomic chemotherapy with low toxicity for the management of castration-resistant prostate cancer.
Jellvert A, Lissbrant IF, Edgren M, Ovferholm E, Braide K, Olvenmark AM, Kindblom J, Albertsson P, Lennernäs B.
Jellvert A, et al.
Exp Ther Med. 2011 Jul;2(4):579-584. doi: 10.3892/etm.2011.272. Epub 2011 May 12.
Exp Ther Med. 2011.
PMID: 22977543
Free PMC article.
Item in Clipboard
Cite
Cite